journal article·2019-02-11Open access

Design, Fabrication, and In Vitro Evaluation of Nanoceria-Loaded Nanostructured Lipid Carriers for the Treatment of Neurological Diseases

Matteo Battaglini, Christos Tapeinos, Ivana Cavaliere, Attilio Marino, Andrea Ancona, Nadia Garino, Valentina Cauda, Francisco Palazon, Doriana Debellis, Gianni Ciofani

Abstract

Neurodegenerative diseases comprise a large group of disorders characterized by a dramatic synaptic connections loss, occurring as a result of neurodegeneration, which is closely related to the overproduction of reactive oxygen and nitrogen species. Currently, the treatment of neurodegenerative diseases has been limited mainly because of the inability of the synthesized delivery systems to cross the blood-brain barrier and to successfully deliver their therapeutic cargo to the diseased tissue. Taking into consideration the aforementioned limitations, we designed a lipid-based nanotherapeutic vector composed of biomimetic lipids and CeO2 nanoparticles (nanoceria, NC). NC have shown to be a promising tool for the treatment of several pathological conditions ranging from cancer to neurological diseases, mainly because of their antioxidant properties, while lipid-based structures have been shown to have an inherent ability to cross the blood-brain barrier. The lipid-based nanotherapeutics were successfully fabricated using a combination of ultrasonication and high-pressure homogenization techniques, and they were fully characterized morphologically and physicochemically. Their antioxidant ability was demonstrated using electron paramagnetic resonance spectroscopy and antioxidant assays. These innovative nanotherapeutics demonstrated a higher colloidal stability with respect to free NC, preserving at the same time their antioxidant properties. Finally, the ability of the lipid carriers to cross a model of the blood-brain barrier and to be internalized by neurons, acting both as neuroprotective and pro-neurogenic agents, was demonstrated using single- and triple-culture systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, 56025 Pontedera, Pisa, Italy

Scuola Superiore Sant’Anna, The Biorobotics Institute, Viale Rinaldo Piaggio 34, 56025 Pontedera, Pisa, Italy

Politecnico di Torino, Department of Mechanical and Aerospace Engineering, Corso Duca degli Abruzzi 24, 10129 Torino, Italy

Politecnico di Torino, Department of Applied Science and Technology, Corso Duca degli Abruzzi 24, 10129 Torino, Italy

Istituto Italiano di Tecnologia, Center for Sustainable Future Technologies, Corso Trento 21, 10129 Torino, Italy

Istituto Italiano di Tecnologia, Nanochemistry, Via Morego 30, 16163 Genova, Italy

Istituto Italiano di Tecnologia, Electron Microscopy Facility, Via Morego 30, 16163 Genova, Italy

Funding

H2020 Marie Sklodowska-Curie Actions · Ministero della Salute

References (39)

Show source-provided references
1. 10.2217/nnm-2016-039910.2217/nnm-2016-0399 ↗
2. 10.1016/j.neuint.2017.05.01110.1016/j.neuint.2017.05.011 ↗
3. 10.1016/j.freeradbiomed.2011.06.00610.1016/j.freeradbiomed.2011.06.006 ↗
4. 10.2147/OTT.S6205710.2147/OTT.S62057 ↗
5. 10.1038/s41598-017-09876-w10.1038/s41598-017-09876-w ↗
6. 10.1039/c0nr00875c10.1039/c0nr00875c ↗
7. 10.1016/j.etap.2016.04.00410.1016/j.etap.2016.04.004 ↗
8. 10.1002/wnan.144410.1002/wnan.1444 ↗
9. 10.3389/fimmu.2017.0189110.3389/fimmu.2017.01891 ↗
10. 10.1086/68959010.1086/689590 ↗
11. 10.1016/j.biomaterials.2015.05.04210.1016/j.biomaterials.2015.05.042 ↗
12. 10.1016/S0378-5173(02)00180-110.1016/S0378-5173(02)00180-1 ↗
13. 10.1016/j.ejps.2012.05.01010.1016/j.ejps.2012.05.010 ↗
14. 10.1016/j.jconrel.2017.08.03310.1016/j.jconrel.2017.08.033 ↗
15. 10.1111/j.1528-1167.2012.03696.x10.1111/j.1528-1167.2012.03696.x ↗
16. 10.3390/nano709027610.3390/nano7090276 ↗
17. 10.1021/acs.langmuir.5b0279710.1021/acs.langmuir.5b02797 ↗
18. 10.1016/j.ajps.2017.05.00310.1016/j.ajps.2017.05.003 ↗
19. Yeruerl G. · Pharmazie · 2004 · 59 · 331
20. 10.1017/S143192761009364510.1017/S1431927610093645 ↗
21. 10.1111/j.1551-2916.2007.02240.x10.1111/j.1551-2916.2007.02240.x ↗
22. 10.1155/2011/80969610.1155/2011/809696 ↗
23. 10.1016/S0074-7696(04)37002-610.1016/S0074-7696(04)37002-6 ↗
24. 10.1016/S0308-8146(02)00282-010.1016/S0308-8146(02)00282-0 ↗
25. 10.1039/C4NR03275F10.1039/C4NR03275F ↗
26. Pham-Huy L. A. · Int. J. Biomed. Sci. · 2008 · 4 · 8910.59566/IJBS.2008.4089 ↗
27. 10.1016/j.btre.2017.11.00810.1016/j.btre.2017.11.008 ↗
28. Wiegand C. · GMS Krankenhaushygiene interdisziplinär · 2008 · 3 · Doc12
29. 10.1602/neurorx.2.1.310.1602/neurorx.2.1.3 ↗
30. 10.1111/jphp.1280310.1111/jphp.12803 ↗
31. 10.1371/journal.pone.018701710.1371/journal.pone.0187017 ↗
32. 10.1159/00047939910.1159/000479399 ↗
33. 10.1016/j.semcdb.2014.08.01110.1016/j.semcdb.2014.08.011 ↗
34. 10.1021/nn100816s10.1021/nn100816s ↗
35. 10.2217/nnm-2016-034210.2217/nnm-2016-0342 ↗
36. 10.1016/j.nano.2015.05.00110.1016/j.nano.2015.05.001 ↗
37. 10.1007/s11095-013-1071-y10.1007/s11095-013-1071-y ↗
38. 10.1016/j.bbagen.2016.11.02210.1016/j.bbagen.2016.11.022 ↗
39. 10.1016/j.bbagen.2013.10.00910.1016/j.bbagen.2013.10.009 ↗